Dr. Michelangelo Certo is a distinguished researcher at the forefront of inflammation and metabolism. He earned his MSc in Pharmaceutical Chemistry and Technology with honours in 2010, followed by a PhD in Cellular Biochemistry and Pharmacology in 2013, both from the University of Calabria, Italy. His early research at the Centre of Preclinical and Translational Pharmacology focused on unravelling the intricate interplay between the immune system and the brain during ischemic injury, with the goal of identifying groundbreaking immunotherapeutic strategies for stroke.
Recognized for his expertise in Pharmacology by the Department Council at the School of Pharmacy, University of Calabria in 2015, Dr. Certo soon after secured a prestigious Research Fellowship from the Italian Society of Pharmacology. This opportunity led him to University College London, where he expanded his research into the realm of chronic pain, applying his deep understanding of inflammatory pathways to uncover novel therapeutic targets.
Throughout his career, Dr. Certo has been driven by a passion for decoding the inflammatory mechanisms that govern immunity, with a strong emphasis on translational medicine. His work spans cell trafficking, target identification, therapeutic exploitation, and the development of reparative and regenerative therapies. In 2017, he transitioned to Barts and The London School of Medicine and Dentistry at Queen Mary University of London, where he explored the metabolic regulation of immune cell function and the role of key metabolites—such as lactate and fatty acids—as powerful signaling molecules in immune-inflammatory responses.
In 2018, Dr. Certo joined the College of Medicine and Health at the University of Birmingham, where he currently serves as a Senior Research Scientist in Metabolism and Inflammation. His research delves into the complex crosstalk between metabolic and inflammatory pathways, investigating their roles in stroke (funded by the University of Birmingham) and chronic inflammatory diseases, including atherosclerosis (funded by the British Heart Foundation) and Sjögren's syndrome (funded by the Medical Research Council). In addition to his research, he also serves as BMSU Departmental Lead, playing a pivotal role in advancing biomedical research and innovation within the university.
With a career dedicated to bridging fundamental research and therapeutic applications, Dr. Certo continues to push the boundaries of knowledge in inflammation, metabolism, and disease intervention.
